The IoT platform developer almost doubled its overall funding with a series C round co-led by returning investor Qualcomm Ventures.

The Alphabet unit formerly known as Google Ventures has strengthened its cancer care by bringing ex-Tesaro head of R&D Sridhar Ramaswamy as an entrepreneur-in-residence.

The Celgene and GV-backed small molecule drug developer floated at the bottom of its range, raising less than half the target it set last week.

Lululemon contributed to a series B-1 round that boosted the total raised by the home fitness system provider to $72m.

University of Pennsylvania spinout Cabaletta has gone public after raising $74.8m in an initial public offering on the Nasdaq Global Select Market.

Prime Medicine will work alongside Harvard University-founded Beam Therapeutics to commercialise Broad Institute faculty vice-chair David Liu's single-base DNA editing inventions.

DST Global has invested $50m to boost Alphabet and Roc Nation-backed trading platform Robinhood’s series E round to $373m.

The Time-backed e-commerce marketing tool provider took its overall funding to $82m in a series C round where TDM Growth Partners joined existing investors.

Novo led the anaemia therapy developer's series A round, which also featured Access Industries subsidiary Access Biotechnology.

Citi Ventures contributed to a late-stage round that will support the upgrading of data integration platform developer Datameer's sales and engineering resources.